Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)

NCT06802133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2025-10-15

No results posted yet for this study

Summary

Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.

Conditions

  • Repair of Dura Mater

Interventions

OTHER

Post Market Study

Prospective case series without a concurrent comparator group.

Sponsors & Collaborators

  • Collagen Matrix

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2026-05-30
Completion
2026-07-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802133 on ClinicalTrials.gov